The FDA has approved perioperative pembrolizumab and enfortumab vedotin for adult patients with muscle-invasive bladder cancer.
Matthew Galsky, MD
Advertisement
Articles by Matthew Galsky, MD
Matthew Galsky, MD, medical oncologist, Icahn School of Medicine at Mount Sinai, discusses treating different subsets of bladder cancer.
Matthew Galsky, MD, medical oncologist, Icahn School of Medicine at Mount Sinai, discusses treatment for lymph node-positive bladder cancer.
Advertisement
Latest Updated Articles
Matthew Galsky on Treating Different Subsets of Bladder CancerAugust 17th 2016
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer
2
Thoracic Oncology Advances and Toxicity Management
3
FDA Approves Zanidatamab-hrii in GEA: Key Takeaways for Oncology Nurses
4
ASCO Releases First Living Guideline for Recurrent Ovarian Cancer Care
5